GPC3 and hepatocellular carcinoma: By introducing molecular indicator, CK19/GPC3 and AFP, the model showed significantly improved recurrence stratification of these patients who met the major HCC staging systems, including MC, UCSF, Fudan and Hangzhou criteria.